| Autor: |
Faurø KK; Department of Clinical Biochemistry, Odense University Hospital, Odense, Denmark., Antonsen S; Department of Clinical Biochemistry, Odense University Hospital Svendborg, Svendborg, Denmark., Nybo M; Department of Clinical Biochemistry, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. |
| Jazyk: |
angličtina |
| Zdroj: |
Scandinavian journal of clinical and laboratory investigation [Scand J Clin Lab Invest] 2024 May; Vol. 84 (3), pp. 174-182. Date of Electronic Publication: 2024 Apr 22. |
| DOI: |
10.1080/00365513.2024.2343906 |
| Abstrakt: |
Critical test results in clinical laboratories are crucial for timely patient care, serving as indicators of potentially life-threatening conditions. Despite their importance, a notable heterogeneity in management practices exists globally. This study investigates the current practices of managing critical results at Danish clinical biochemistry laboratories and identifies areas prone for improvement. A comprehensive online survey was distributed to all 21 Danish clinical biochemistry laboratories regarding their critical result management, including documentation practices, critical limit selection, and quality assurance measures. A total of 17 laboratories (81%) responded. The answers revealed a generally uniform approach to managing critical results, with all laboratories having 24-h reporting, local instructions and using the telephone as communication channel. However, variations were noted in documentation practices and critical limit selection. Notably, 23.5% of the laboratories reported that one out of every ten critical results was not reported, indicating a significant risk of delayed critical results. This is further complicated by the limited use of predefined timeframes for reporting and also, only few laboratories actively monitored response times. The findings emphasize the need for more standardized documentation and evaluation practices to align with international standards and to enhance patient safety. While the laboratories showed a commitment to standardized procedures, the study emphasizes the necessity of a National or Nordic guideline to supplement the ISO 15189:2022. This study is a step towards optimizing critical result management, not only in Danish clinical biochemistry laboratories but also across various laboratory specialties, thereby improving overall laboratory quality, efficiency, and patient safety. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
